Clinical Trial Update: Demographic and Clinical Predictors of Persistence in Patients Treated With Aripiprazole Once-monthly in Italy

View source ↗

Summary

A completed Italian study assessing demographic and clinical predictors of persistence in schizophrenia patients treated with aripiprazole once-monthly.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Aripiprazole Once Monthly (aripiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Europe Ltd | Conditions: Schizophrenia | Status: COMPLETED